Pfizer Inc applied to US health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first application of its kind in an important step to provide protection against the novel coronavirus. The application to the US Food and Drug Administration (FDA) comes just days after Pfizer …
Read More »
Friday was an important day in the global fight against Covid-19. The day was held an informal meeting of the Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organization (WTO) to discuss a proposal made by India and South Africa in October, and that since …
Read More »
Prime Minister Narendra Modi held a meeting on Friday to review India’s vaccination strategy in which issues such as prioritization of population groups and the technological platform for the deployment of the vaccine for the coronavirus were discussed. Modi tweeted that the meeting discussed important topics related to the progress …
Read More »
Written by Abhishek De, edited by Explained Desk | New Delhi | Updated: November 20, 2020 4:07:53 pm An actor dressed as a coronavirus reacts after injecting a fantasy vaccine during a street performance in Plaza San Martín (AP) Encouraging results in Covid-19 vaccine trials by pioneers in November have …
Read More »
Written by Kaunain Sheriff M | New Delhi | Updated: November 20, 2020 9:52:14 am “Further evaluation of the efficacy of this vaccine is warranted in all age groups and individuals with comorbidities,” the researchers said. The Oxford-AstraZeneca Covid-19 candidate vaccine has triggered a robust immune response in older adults …
Read More »
NEW DELHI: The CEO of vaccine maker Serum Institute of India, Adar Poonawalla, said Thursday that the Oxford Covid-19 vaccine should be available to healthcare workers and seniors around February 2021 and in April for the general public, and will have a maximum price of Rs 1,000 for two doses …
Read More »
NEW DELHI: The CEO of vaccine maker Serum Institute of India, Adar Poonawalla, said Thursday that the Oxford Covid-19 vaccine should be available to healthcare workers and seniors around February 2021 and in April for the general public, and will have a maximum price of Rs 1,000 for two doses …
Read More »
The Oxford-AstraZeneca vaccine for coronavirus disease could be available to the general public between April and May next year and is likely to cost around ₹ 500-600 per dose, the executive director of the Serum Institute of India said on Thursday. , Adar Poonawalla, adding that he expects the long-awaited …
Read More »
It was in 2011, shortly after assuming the role of CEO of the Serum Institute of India (SII), that Adar Poonawalla set out to double the capacity of what is now the world’s largest vaccine manufacturer by volume. Initially motivated by economies of scale, Poonawalla, whose father Cyrus founded the …
Read More »
COVID-19 vaccines are likely to be a reality soon. Several candidates in the global coronavirus vaccine race have come a little closer to regulatory approval in recent weeks. “The coronavirus vaccine will be available in the coming months and it is estimated that between 400 and 500 million doses will …
Read More »